PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects.
PharmaBlock, a contract development and manufacturing organization focused on innovative chemistry and low-carbon manufacturing, announced on March 27, 2023 the opening of its new R&D facility in West Chester, Pa. The facility will expand the company’s footprint in the United States and increase its capacity to delivery good manufacturing practice (GMP) projects to global partners.
The new site includes 30,000 ft2 of lab space and includes process R&D labs, GMP suites, clean rooms, and GMP analytical labs. The site also enables flow chemistry, micro-packed bed hydrogenation, and solid-state chemistry capabilities. The site joins the company’s existing facility in Hatfield, Pa., and is a crucial addition to enhancing the delivery of clinical-stage API projects, according to a company press release.
"We are excited to celebrate the grand opening of our new research facility, which represents a significant milestone for our company," said Jing Li, president of PharmaBlock, in the release. "This state-of-the-art facility will enable us to provide our clients with the highest quality research and development solutions, and we look forward to continuing to innovate and advance."
Source: PharmaBlock
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.